Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningioma | 2 | 2023 | 1209 | 0.910 |
Why?
|
Meningeal Neoplasms | 2 | 2023 | 1241 | 0.890 |
Why?
|
Glioblastoma | 8 | 2023 | 3456 | 0.870 |
Why?
|
Lewy Body Disease | 1 | 2023 | 226 | 0.780 |
Why?
|
Brain Neoplasms | 16 | 2023 | 8829 | 0.670 |
Why?
|
MicroRNAs | 8 | 2023 | 3731 | 0.650 |
Why?
|
Oligonucleotides | 2 | 2019 | 572 | 0.640 |
Why?
|
Astrocytes | 9 | 2017 | 1266 | 0.570 |
Why?
|
Cell Culture Techniques | 2 | 2021 | 1670 | 0.490 |
Why?
|
Tumor Cells, Cultured | 3 | 2021 | 6313 | 0.480 |
Why?
|
Erythrocyte Transfusion | 2 | 2013 | 565 | 0.460 |
Why?
|
Intracranial Hemorrhages | 6 | 2023 | 854 | 0.450 |
Why?
|
Plasma Exchange | 1 | 2013 | 155 | 0.420 |
Why?
|
Blood Group Incompatibility | 1 | 2013 | 145 | 0.420 |
Why?
|
Tuberous Sclerosis | 7 | 2005 | 1029 | 0.420 |
Why?
|
Hemolysis | 1 | 2013 | 420 | 0.390 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2723 | 0.350 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2009 | 66 | 0.330 |
Why?
|
Neurofibromatoses | 1 | 2012 | 299 | 0.310 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2004 | 104 | 0.300 |
Why?
|
Relapsing Fever | 1 | 2007 | 19 | 0.300 |
Why?
|
Cell Division | 6 | 2004 | 4564 | 0.300 |
Why?
|
Borrelia | 1 | 2007 | 67 | 0.290 |
Why?
|
Glioma | 4 | 2023 | 3388 | 0.280 |
Why?
|
Monomeric GTP-Binding Proteins | 2 | 2004 | 199 | 0.270 |
Why?
|
Proteins | 6 | 2004 | 6096 | 0.260 |
Why?
|
Delavirdine | 1 | 2004 | 7 | 0.260 |
Why?
|
Anemia, Sickle Cell | 1 | 2013 | 1017 | 0.250 |
Why?
|
Venous Thromboembolism | 4 | 2018 | 1668 | 0.240 |
Why?
|
Factor VII | 1 | 2004 | 139 | 0.240 |
Why?
|
Tumor Suppressor Proteins | 11 | 2005 | 2842 | 0.230 |
Why?
|
HIV Reverse Transcriptase | 1 | 2004 | 213 | 0.230 |
Why?
|
Enoxaparin | 2 | 2017 | 377 | 0.230 |
Why?
|
Cerebral Infarction | 1 | 2009 | 1007 | 0.230 |
Why?
|
Lewy Bodies | 1 | 2023 | 133 | 0.220 |
Why?
|
Anticoagulants | 5 | 2022 | 4595 | 0.220 |
Why?
|
Oligodendroglioma | 1 | 2023 | 279 | 0.210 |
Why?
|
Cystatins | 1 | 2001 | 55 | 0.210 |
Why?
|
Astrocytoma | 2 | 2023 | 789 | 0.200 |
Why?
|
RNA, Small Nuclear | 1 | 2022 | 65 | 0.200 |
Why?
|
Neuropeptides | 2 | 2004 | 942 | 0.200 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2004 | 615 | 0.200 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 2001 | 124 | 0.190 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2001 | 79 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2023 | 8425 | 0.190 |
Why?
|
Receptor, IGF Type 1 | 1 | 2023 | 390 | 0.190 |
Why?
|
Blood Component Removal | 1 | 2001 | 125 | 0.190 |
Why?
|
Postoperative Hemorrhage | 1 | 2004 | 409 | 0.190 |
Why?
|
Lung Transplantation | 1 | 2009 | 1155 | 0.180 |
Why?
|
Central Nervous System | 2 | 2004 | 1354 | 0.180 |
Why?
|
Genes, bcl-2 | 1 | 1998 | 122 | 0.160 |
Why?
|
Repressor Proteins | 5 | 2003 | 3020 | 0.160 |
Why?
|
Germinal Center | 1 | 2020 | 377 | 0.160 |
Why?
|
Hippocampus | 3 | 2015 | 3661 | 0.150 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6171 | 0.150 |
Why?
|
RNA Splicing | 1 | 2022 | 907 | 0.150 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2018 | 339 | 0.140 |
Why?
|
Pulmonary Embolism | 1 | 2009 | 2370 | 0.140 |
Why?
|
Oncogenes | 1 | 2022 | 1263 | 0.130 |
Why?
|
Caspases | 1 | 1998 | 928 | 0.130 |
Why?
|
Cell Survival | 2 | 2023 | 5872 | 0.130 |
Why?
|
E2F1 Transcription Factor | 1 | 2015 | 190 | 0.120 |
Why?
|
Cell Cycle Proteins | 3 | 2003 | 3444 | 0.120 |
Why?
|
Muscular Diseases | 1 | 2019 | 557 | 0.120 |
Why?
|
Cell Line, Tumor | 5 | 2023 | 16665 | 0.120 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6608 | 0.120 |
Why?
|
Fever | 1 | 2001 | 1612 | 0.120 |
Why?
|
Oligonucleotides, Antisense | 1 | 2016 | 433 | 0.120 |
Why?
|
Humans | 44 | 2023 | 742088 | 0.110 |
Why?
|
Epilepsy | 3 | 2005 | 3301 | 0.110 |
Why?
|
Cell Proliferation | 4 | 2023 | 10472 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2003 | 322 | 0.110 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2014 | 694 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2020 | 1379 | 0.110 |
Why?
|
Leukocytes | 1 | 2001 | 2039 | 0.110 |
Why?
|
rap1 GTP-Binding Proteins | 2 | 2003 | 60 | 0.110 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2023 | 3067 | 0.110 |
Why?
|
Cranial Irradiation | 1 | 2015 | 401 | 0.110 |
Why?
|
Cell Nucleus | 1 | 2022 | 2968 | 0.110 |
Why?
|
Mutation | 6 | 2023 | 29717 | 0.110 |
Why?
|
Guillain-Barre Syndrome | 1 | 2014 | 123 | 0.110 |
Why?
|
Apoptosis | 3 | 2015 | 9715 | 0.110 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 895 | 0.110 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2014 | 657 | 0.100 |
Why?
|
Dexamethasone | 1 | 2019 | 1949 | 0.100 |
Why?
|
Alopecia | 1 | 2015 | 381 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1377 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1509 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2001 | 2145 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 5171 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2019 | 2107 | 0.090 |
Why?
|
Hyperammonemia | 1 | 2010 | 76 | 0.090 |
Why?
|
Genes, Tumor Suppressor | 2 | 2005 | 1097 | 0.090 |
Why?
|
Ammonia | 1 | 2010 | 239 | 0.090 |
Why?
|
Hepatic Encephalopathy | 1 | 2010 | 139 | 0.080 |
Why?
|
Anti-HIV Agents | 1 | 2004 | 4250 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2940 | 0.080 |
Why?
|
Radiation Injuries | 1 | 2015 | 1178 | 0.080 |
Why?
|
Neurofibromatosis 2 | 1 | 2012 | 380 | 0.080 |
Why?
|
Occupational Therapy | 1 | 2009 | 134 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4664 | 0.070 |
Why?
|
Animals | 17 | 2022 | 168561 | 0.070 |
Why?
|
Mice, Knockout | 6 | 2005 | 14554 | 0.070 |
Why?
|
Cells, Cultured | 8 | 2005 | 19223 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1659 | 0.070 |
Why?
|
Syndrome | 1 | 2013 | 3248 | 0.070 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 562 | 0.070 |
Why?
|
Anastomosis, Surgical | 1 | 2009 | 985 | 0.060 |
Why?
|
Gliosis | 2 | 2003 | 243 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2003 | 4553 | 0.060 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2005 | 150 | 0.060 |
Why?
|
Contact Inhibition | 1 | 2004 | 48 | 0.060 |
Why?
|
Neurons | 3 | 2004 | 9325 | 0.060 |
Why?
|
Mice | 13 | 2022 | 81045 | 0.060 |
Why?
|
Antigens, Neoplasm | 3 | 2022 | 1983 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13019 | 0.060 |
Why?
|
RNA Interference | 2 | 2022 | 2890 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1847 | 0.060 |
Why?
|
Radiography | 2 | 2020 | 7010 | 0.060 |
Why?
|
Aged | 10 | 2023 | 162944 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2013 | 1575 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4933 | 0.060 |
Why?
|
Factor VIIa | 1 | 2004 | 101 | 0.060 |
Why?
|
Transfection | 4 | 2004 | 5892 | 0.050 |
Why?
|
Male | 13 | 2023 | 349538 | 0.050 |
Why?
|
DNA Primers | 2 | 1998 | 2892 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 1596 | 0.050 |
Why?
|
Species Specificity | 1 | 2007 | 2479 | 0.050 |
Why?
|
Echocardiography, Transesophageal | 1 | 2009 | 1129 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2004 | 473 | 0.050 |
Why?
|
Cell Size | 1 | 2004 | 643 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2018 | 62966 | 0.050 |
Why?
|
Brain | 4 | 2023 | 26343 | 0.050 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2001 | 91 | 0.050 |
Why?
|
Base Sequence | 3 | 2017 | 12797 | 0.050 |
Why?
|
Spliceosomes | 1 | 2022 | 110 | 0.050 |
Why?
|
Glutamic Acid | 2 | 2005 | 1167 | 0.050 |
Why?
|
Potassium | 1 | 2005 | 1336 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8333 | 0.050 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2022 | 194 | 0.050 |
Why?
|
Blood Coagulation Disorders | 1 | 2004 | 337 | 0.050 |
Why?
|
Glyceryl Ethers | 1 | 2000 | 4 | 0.050 |
Why?
|
Cystatin C | 1 | 2001 | 250 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3611 | 0.050 |
Why?
|
Oligoribonucleotides | 1 | 2000 | 51 | 0.050 |
Why?
|
Blotting, Western | 3 | 2003 | 5180 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 1998 | 1434 | 0.050 |
Why?
|
Thionucleotides | 1 | 2000 | 107 | 0.050 |
Why?
|
Platelet Activation | 1 | 2004 | 671 | 0.050 |
Why?
|
Protein Kinases | 2 | 2004 | 1638 | 0.050 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1178 | 0.040 |
Why?
|
Angiomyolipoma | 1 | 2001 | 186 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2002 | 678 | 0.040 |
Why?
|
Down-Regulation | 2 | 2004 | 3001 | 0.040 |
Why?
|
Retrospective Studies | 8 | 2023 | 77098 | 0.040 |
Why?
|
Neurofibromin 2 | 1 | 2001 | 267 | 0.040 |
Why?
|
Drug Resistance, Viral | 1 | 2004 | 820 | 0.040 |
Why?
|
Neurofibromin 1 | 1 | 2001 | 196 | 0.040 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 1998 | 68 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2004 | 1871 | 0.040 |
Why?
|
Mutagenesis | 2 | 2003 | 1263 | 0.040 |
Why?
|
Nerve Growth Factors | 1 | 2001 | 576 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57683 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2010 | 2736 | 0.040 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2023 | 870 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1998 | 190 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2004 | 2107 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2000 | 508 | 0.040 |
Why?
|
Immunoassay | 1 | 2001 | 752 | 0.040 |
Why?
|
Neuroglia | 1 | 2003 | 925 | 0.040 |
Why?
|
Endocytosis | 1 | 2002 | 983 | 0.040 |
Why?
|
Adult | 10 | 2020 | 213712 | 0.040 |
Why?
|
Signal Transduction | 5 | 2015 | 23387 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2022 | 1118 | 0.040 |
Why?
|
Telomerase | 1 | 2001 | 729 | 0.030 |
Why?
|
Incidence | 3 | 2018 | 20928 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2004 | 1171 | 0.030 |
Why?
|
Adenovirus E1A Proteins | 1 | 1995 | 76 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1998 | 563 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1423 | 0.030 |
Why?
|
Heterozygote | 1 | 2002 | 2790 | 0.030 |
Why?
|
Young Adult | 4 | 2017 | 56350 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13655 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6534 | 0.030 |
Why?
|
Up-Regulation | 1 | 2004 | 4211 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2000 | 3133 | 0.030 |
Why?
|
Miller Fisher Syndrome | 1 | 2014 | 7 | 0.030 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2014 | 45 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2015 | 400 | 0.030 |
Why?
|
Reference Values | 1 | 2001 | 4982 | 0.030 |
Why?
|
Adenoviridae | 1 | 1998 | 1096 | 0.030 |
Why?
|
Middle Aged | 9 | 2020 | 213127 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5462 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2011 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2003 | 1699 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12958 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3800 | 0.030 |
Why?
|
Female | 11 | 2020 | 379592 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2014 | 212 | 0.030 |
Why?
|
Gangliosides | 1 | 2014 | 140 | 0.030 |
Why?
|
Scalp | 1 | 2015 | 380 | 0.030 |
Why?
|
Herpesvirus 3, Human | 1 | 2014 | 204 | 0.030 |
Why?
|
RNA, Messenger | 4 | 2003 | 13029 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1899 | 0.030 |
Why?
|
Genotype | 2 | 2004 | 12946 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2001 | 1093 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2014 | 388 | 0.030 |
Why?
|
Virus Activation | 1 | 2014 | 319 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2183 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 1998 | 849 | 0.030 |
Why?
|
Phenotype | 3 | 2004 | 16331 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1996 | 1526 | 0.030 |
Why?
|
Fibroblasts | 1 | 2002 | 4143 | 0.030 |
Why?
|
Herpes Zoster | 1 | 2014 | 264 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2003 | 13814 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8621 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 3913 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3278 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 3769 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 1996 | 987 | 0.020 |
Why?
|
Cerebral Cortex | 2 | 2010 | 5705 | 0.020 |
Why?
|
Radiometry | 1 | 2015 | 800 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2917 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2003 | 18112 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2016 | 1126 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3564 | 0.020 |
Why?
|
Autoantigens | 1 | 2014 | 891 | 0.020 |
Why?
|
Consciousness Disorders | 1 | 2014 | 418 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2015 | 806 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2015 | 2876 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2885 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1998 | 3420 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2004 | 7901 | 0.020 |
Why?
|
Remission Induction | 1 | 2014 | 2384 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2004 | 5522 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2004 | 9410 | 0.020 |
Why?
|
Cell Line | 2 | 2001 | 15994 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4465 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29010 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18006 | 0.020 |
Why?
|
Electroencephalography | 1 | 2002 | 6142 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3557 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2004 | 11470 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1995 | 2440 | 0.020 |
Why?
|
Survival Rate | 2 | 2015 | 12773 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2012 | 1606 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9963 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 21596 | 0.020 |
Why?
|
Ultrasonography | 1 | 2019 | 5978 | 0.020 |
Why?
|
Risk Factors | 3 | 2018 | 72145 | 0.020 |
Why?
|
Software | 1 | 2020 | 4434 | 0.020 |
Why?
|
Glycoproteins | 1 | 2014 | 2260 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 1996 | 2948 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2003 | 2837 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2005 | 191 | 0.020 |
Why?
|
Autoantibodies | 1 | 2014 | 2036 | 0.020 |
Why?
|
Models, Biological | 1 | 2022 | 9581 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2633 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2001 | 4229 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 35342 | 0.020 |
Why?
|
Adolescent | 3 | 2010 | 85649 | 0.020 |
Why?
|
Indoles | 1 | 2012 | 1834 | 0.010 |
Why?
|
Thalamus | 1 | 2010 | 1023 | 0.010 |
Why?
|
Extracellular Space | 1 | 2005 | 594 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2001 | 7873 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2003 | 349 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4024 | 0.010 |
Why?
|
Sulfonamides | 1 | 2012 | 1932 | 0.010 |
Why?
|
Cerebellum | 1 | 2010 | 1490 | 0.010 |
Why?
|
Hypertrophy | 1 | 2004 | 568 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2004 | 524 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2012 | 2028 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9305 | 0.010 |
Why?
|
Antisense Elements (Genetics) | 1 | 2001 | 37 | 0.010 |
Why?
|
Guanosine Triphosphate | 1 | 2003 | 321 | 0.010 |
Why?
|
Integrases | 1 | 2004 | 533 | 0.010 |
Why?
|
Genome, Human | 1 | 2015 | 4420 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 2004 | 9735 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39004 | 0.010 |
Why?
|
Giant Cells | 1 | 2001 | 187 | 0.010 |
Why?
|
Simian virus 40 | 1 | 2001 | 295 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7721 | 0.010 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2001 | 258 | 0.010 |
Why?
|
Oligoribonucleotides, Antisense | 1 | 2000 | 15 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11001 | 0.010 |
Why?
|
Electrophysiology | 1 | 2003 | 1309 | 0.010 |
Why?
|
Codon, Initiator | 1 | 2000 | 52 | 0.010 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2000 | 82 | 0.010 |
Why?
|
Recovery of Function | 1 | 2010 | 2924 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2004 | 1586 | 0.010 |
Why?
|
Acute Disease | 1 | 2010 | 7141 | 0.010 |
Why?
|
Gene Expression | 2 | 2003 | 7790 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2004 | 1144 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 1995 | 9639 | 0.010 |
Why?
|
Melanocytes | 1 | 2001 | 515 | 0.010 |
Why?
|
ras Proteins | 1 | 2003 | 1060 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2001 | 11363 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2003 | 2723 | 0.010 |
Why?
|
Radiation Tolerance | 1 | 2000 | 484 | 0.010 |
Why?
|
Phosphorylation | 2 | 2001 | 8436 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21719 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2001 | 933 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23320 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 3701 | 0.010 |
Why?
|
Genes, ras | 1 | 2000 | 691 | 0.010 |
Why?
|
Gene Amplification | 1 | 2001 | 1062 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40054 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 867 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2126 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1284 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2003 | 3847 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2003 | 1525 | 0.010 |
Why?
|
Molecular Structure | 1 | 2000 | 1907 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 9274 | 0.010 |
Why?
|
Alcohol Oxidoreductases | 1 | 1995 | 170 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2000 | 1274 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2003 | 2502 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 40450 | 0.010 |
Why?
|
Synapses | 1 | 2003 | 1724 | 0.010 |
Why?
|
Actins | 1 | 2001 | 2120 | 0.010 |
Why?
|
Mice, Nude | 1 | 2000 | 3689 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11472 | 0.010 |
Why?
|
Homeostasis | 1 | 2003 | 3335 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15530 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1995 | 1202 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4322 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2001 | 3278 | 0.010 |
Why?
|
HeLa Cells | 1 | 1995 | 3127 | 0.010 |
Why?
|
Child | 2 | 2010 | 77478 | 0.000 |
Why?
|
Binding Sites | 1 | 1995 | 6115 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1995 | 4801 | 0.000 |
Why?
|
Protein Binding | 1 | 1995 | 9387 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1995 | 5095 | 0.000 |
Why?
|
Transcription Factors | 1 | 2001 | 12164 | 0.000 |
Why?
|
Infant | 1 | 2001 | 35070 | 0.000 |
Why?
|
Child, Preschool | 1 | 2001 | 40955 | 0.000 |
Why?
|